The Department has broad research interests in clinical psychiatry, including old-age psychiatry, use of evidence-based medicine approaches to identify best treatments for acute mania and Generalized Anxiety Disorder; assessment of clinical toxicity associated with synthetic cannabinoids; audit of ECT use in Otago; Bayesian analysis of suicide data, etc.
We have a number of planned and ongoing studies in patients with:
- severe social anxiety disorder or generalized anxiety disorder
- chronic schizophrenia
- adherence to medications based on HBM
- dementia prevention
- association of anxiety and dementia
- children and adolescents with ADHD
as well as working with healthy volunteers.
If you would like to find out more about these studies please visit the Clinical Trials section on this website.